You are here

relapsing multiple sclerosis

Janssen’s Ponesimod Finds Success in Head-to-Head Multiple Sclerosis Trial

Janssen’s Ponesimod Finds Success in Head-to-Head Multiple Sclerosis Trial

BioSpace

relapsing multiple sclerosis

Flag link:

3 Drugs Under FDA Review With Blockbuster Potential

3 Drugs Under FDA Review With Blockbuster Potential

Motley Fool

rheumatoid arthritis

wet age-related macular degeneration

relapsing multiple sclerosis

Flag link:

FDA approves Novartis' Mayzent for MS

FDA approves Novartis' Mayzent for MS

BioCentury

relapsing multiple sclerosis

Flag link:

Roche unveils long-term data from MS blockbuster Ocrevus

Roche unveils long-term data from MS blockbuster Ocrevus

Pharmaforum

relapsing multiple sclerosis

Flag link:

Celgene's Ozanimod Reduces Relapses and Brain Volume Loss in MS Patients in Phase III Trials

Celgene's Ozanimod Reduces Relapses and Brain Volume Loss in MS Patients in Phase III Trials

CP Wire

relapsing multiple sclerosis

Flag link: